The well-established biological functions of FGF21 as a key regulator of energy balance, glucose homeostasis, fat metabolism and insulin sensitivity provide clues as to the SLC6A19 loss-associated protection against obesity and metabolic syndrome. This evidence concerns the gene FGF21 and obesity due to melanocortin 4 receptor deficiency.